|
|
|
|
|
| June 18,
2010 | ISSUE NUMBER 153 VOL 8 |
Live From DIA
Industry Braces for Reform
From comparative effectiveness research to electronic health records in clinical trials, this year's meeting of the Drug Information Association was all about sweeping changes in the wake of healthcare reform. However, the big question everyone was asking was how do we do it and how much will it cost?
Hamburg Calls for Better Regulatory Science
During a keynote speech, FDA Commissioner Margaret Hamburg explained that industry is lacking the science and tools to assess and evaluate safety and efficacy. In other words, the US needs to beef up its regulatory science ASAP.
Advertisement:
The Health Care Reform Opportunity: Implications and Recommendations for Life Sciences
Is health care reform a tough pill to swallow for your business? Although reform is changing the landscape, it is rife with opportunity. A report from Capgemini Consulting examines the challenges and implications resulting from health care reform and offers recommendations on how capitalize on the shifts within the industry.
 Download here
|
Pharma and Cloud Computing: Are We There Yet?
Hosted applications on a cloud-based platform is all the rage, but the pharmaceutical industry has never been trendy (to say the least). Microsoft's Michael Naimoli walks Pharm Exec through why pharma should consider making the move into the cloud.
New & Noteworthy
Tech Toys 2: Revenge of the App
The new world of mobile applications is sparking creative platforms for reaching consumers and physicians.
|
| 
|
 // KV Pharmaceuticals added Mark Dow, Gregory Bentley, and Joseph Lehrer to its board and appointed Gregory Divis its new interim president and CEO.
// aTyr Pharma hired Catharine Johnson as SVP of business development. She had been VP of corporate development at Momenta Pharmaceuticals.
// Novavax added two Heads to its manufacturing management team: John Madsen, for process and manufacturing operations; and Steven Pincus for analyticsl and quality operations.
// OXIS International appointed Thomas Hood to its board.
// Charles Maroney joined Cardiva Medical as its new president and CEO.
|
|
|
Jun 22–23 Disease Education and Bio/Pharmaceutical Product Promotion Using Social Media Tools
Alexandria, VA
Jun 28–29 Clinical R&D Compliance Forum
Philadelphia, PA
Jul 26–27 Bio/Pharmaceutical Summit: Optimize Market Research and to Drive Accurate Product Forecasts
Philadelphia, PA
Jul 29–30 5th Annual Congress on Clinical Supply Chain Management
Princeton, NJ
Sep 9–10 Clinical Trials in Latin America
Lima, Peru
Sep 29–30 6th Annual Bio/Pharmaceutical and Medical Device Product Recalls Summit
Washington, DC
Oct 5-6 International Diabetes Summit
Dubai, UAE
|
|
|
|
 |
|
 |
|
 |
| A year and a half into President Obama's tenure, how do you view the effectiveness of the "new" FDA? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
